Presentation and Status in Health Basket
| Presentation | Basket | Yarpa | Pharmasoft |
|---|---|---|---|
|
Tablets 30 X 5 mg |
|
89473 | 20635 |
Related information
Dosage
See prescribing information for full details.
Indications
For symptomatic treatment of urinary obstruction caused by benign prostatic hypertrophy (BPH). For mild to moderate hypertension.
Contra-Indications
Known hypersensitivity to terazosin HCl or any component of the product.
Special Precautions
See prescribing information for full details.
Side Effects
See prescribing information for full details.
Drug interactions
Caution should be observed when administered concomitantly with other antihypertensive agents, especially the calcium channel blocker verapamil, to avoid the possibility of developing significant hypotension. When using with other antihypertensive agents concomitantly, dosage reduction and retitration of either agent may be necessary.
See prescribing information for full details.
